NewsBenzingaユナイテッド・コミュニティ・バンクス、第3四半期調整後EPSは0.77ドルで予想通り、売上高は2億9,190万5,000ドルで予想2億8,254万ドルを上回る ユナイテッド・コミュニティ・バンクス、第3四半期調整後EPSは0.77ドルで予想通り、売上高は2億9,190万5,000ドルで予想2億8,254万ドルを上回る Benzinga 2026.10.20 11:08 (GMT+0) Open on Benzinga Other news 3M CEO Says Expanded Beam Optics Sales Could Likely Double Next Year Strive Closes Upsized $630M IPO Of 15% Series A Perpetual SATS Preferred Stock At $90/Share; Shares Expected To Begin Trading On Nasdaq Global Market Around October 20, 2026, Under Ticker 'SATS' RBC Capital Maintains Outperform on argenx, Lowers Price Target to $1025 Piper Sandler Maintains Overweight on Axon Enterprise, Lowers Price Target to $561 Eloxx Pharmaceuticals Finalizes Design For Its EXPRESS Phase 2 Global Trial In Nonsense-Mutation Autosomal Dominant Polycystic Kidney Disease To Enrolol 60 Adults With Genetically Confirmed PKD1 Or PKD2 Nonsense Mutations Genuine Parts Q3 2026 Earnings Call Transcript
Strive Closes Upsized $630M IPO Of 15% Series A Perpetual SATS Preferred Stock At $90/Share; Shares Expected To Begin Trading On Nasdaq Global Market Around October 20, 2026, Under Ticker 'SATS'
Eloxx Pharmaceuticals Finalizes Design For Its EXPRESS Phase 2 Global Trial In Nonsense-Mutation Autosomal Dominant Polycystic Kidney Disease To Enrolol 60 Adults With Genetically Confirmed PKD1 Or PKD2 Nonsense Mutations
